HCPCS code J0688 — Inj cefazolin sodium, hikma. Status: Active. Effective Jan 1, 2025. Source: CMS HCPCS Level II.

J0688

Active

Inj cefazolin sodium, hikma

Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2025
Code type: alphanumeric
OPPS Status: N — Items / services packaged into APC rates

MUE — Medically Unlikely Edits

Maximum units of J0688 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 16
Outpatient Hospital 16
Practitioner Services 16

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
00143-9139-25 Cefazolin Sodium
00143-9140-25 Cefazolin Sodium

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q1
    Inj cefazolin sodium, hikma